In today’s world, the Health-Tech industry is going through significant changes. The landscape is very dynamic and rapidly evolving. We envision Health-Tech as leveraging technology and innovation to create efficiency, efficacy, and affordability for the five major constituents of healthcare offerings — patients, physicians, payers, healthcare systems/infrastructure and pharmaceuticals/therapeutics.
We at WCP, combine investment banking experience with industry expertise. The Health-Tech team’s main areas of focus include:
- Digital Health: Emphasizes domains such as tele-health, remote patient monitoring, wearables, computer vision, and data analytics;
- Life Sciences and Diagnostics: Focuses on life sciences tools as well as remote/portable diagnostics, genomics, next generation digital therapeutics, and technologies catalyzing drug discovery and development.
Sell-side and Buy-side M&A
Asli Aras, Ph.D.
Life Sciences and Diagnostics
Juliesta Sylvester, Ph.D.
Molecular and Data Analytics
Prior to joining WCP, Juliesta was Head of the Global Data and Innovation divisions at Diaceutics, where she built, priced, and brought to market a suite of data products and analytical services that transformed the privately-owned consulting company into a publicly traded technology company on the LSE.
Vini brings deep experience in corporate finance transactions across the digital health sector.
Reports & News
Embedded Vision Summit Presentation - Vision Opportunities in Healthcare by Vini Jolly, Executive Director, Health Tech Team, Woodside Capital Partners
The team lives and breathes technology. We stay on top of emerging technology trends through constant engagement with leading startups, corporations, strategic investors, and health tech-focused venture capital and private equity firms.